Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Meacham

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Plos One|August 21, 2012
Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cellsEric Bartee, Amy Meacham, Elizabeth Wise, et al.
Journal of Medicinal Chemistry|July 12, 2018
Exploring the Structure-Activity Relationship and Mechanism of a Chromene Scaffold (CXL Series) for Its Selective Antiproliferative Activity toward Multidrug-Resistant Cancer CellsTengfei Bian, Kavitha Chandagirikoppal Vijendra, Yi Wang, et al.
Leukemia Research|July 20, 2015
Endothelial cell derived angiocrine support of acute myeloid leukemia targeted by receptor tyrosine kinase inhibitionLeylah Drusbosky, Eric Gars, Angelica Trujillo, et al.
Leukemia Research|February 21, 2012
Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitroGerard J Madlambayan, Eric Bartee, Manbok Kim, et al.
Experimental Hematology|February 23, 2016
Chemosensitizing AML cells by targeting bone marrow endothelial cellsRaphael C Bosse, Briana Wasserstrom, Amy Meacham, et al.
Leukemia Research|January 15, 2019
Computational modeling of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) to identify personalized therapy using genomicsAnsu Kumar, Leylah M Drusbosky, Amy Meacham, et al.
Leukemia|March 19, 2014
Functional integration of acute myeloid leukemia into the vascular nicheChristopher R Cogle, Devorah C Goldman, Gerard J Madlambayan, et al.
Blood Advances|June 19, 2019
A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patientsLeylah M Drusbosky, Neeraj Kumar Singh, Kimberly E Hawkins, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Plos One|August 21, 2012
Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cellsEric Bartee, Amy Meacham, Elizabeth Wise, et al.
Journal of Medicinal Chemistry|July 12, 2018
Exploring the Structure-Activity Relationship and Mechanism of a Chromene Scaffold (CXL Series) for Its Selective Antiproliferative Activity toward Multidrug-Resistant Cancer CellsTengfei Bian, Kavitha Chandagirikoppal Vijendra, Yi Wang, et al.
Leukemia Research|July 20, 2015
Endothelial cell derived angiocrine support of acute myeloid leukemia targeted by receptor tyrosine kinase inhibitionLeylah Drusbosky, Eric Gars, Angelica Trujillo, et al.
Leukemia Research|February 21, 2012
Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitroGerard J Madlambayan, Eric Bartee, Manbok Kim, et al.
Experimental Hematology|February 23, 2016
Chemosensitizing AML cells by targeting bone marrow endothelial cellsRaphael C Bosse, Briana Wasserstrom, Amy Meacham, et al.
Leukemia Research|January 15, 2019
Computational modeling of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) to identify personalized therapy using genomicsAnsu Kumar, Leylah M Drusbosky, Amy Meacham, et al.
Leukemia|March 19, 2014
Functional integration of acute myeloid leukemia into the vascular nicheChristopher R Cogle, Devorah C Goldman, Gerard J Madlambayan, et al.
Blood Advances|June 19, 2019
A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patientsLeylah M Drusbosky, Neeraj Kumar Singh, Kimberly E Hawkins, et al.
Pageof 1